Could Maternal RSV Vaccination Be the Preferred Option?
MDSpire News
August 7, 2026
You now have access to the trusted editorial news and specialty content you've known from the Conexiant news site—all within the MDSpire experience.
Learn more

Pregnant women and parents preferred maternal vaccination over infant antibody administration for RSV protection.
Fifty-eight percent of pregnant women favored maternal vaccination, while only 6% preferred infant antibody shots.
A strong physician recommendation increased vaccine acceptance among hesitant respondents, with 36% of initially negative pregnant women willing to reconsider.
Concerns about vaccine safety for mothers and infants were the primary reasons for hesitancy among pregnant women.
The survey highlighted information gaps and the need for improved communication strategies regarding RSV immunization.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Affiliations:
Specialties:
Areas of Expertise: